SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020524
Filing Date
2018-08-08
Accepted
2018-08-08 16:32:25
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20180630.htm 10-Q 1563939
2 EX-10.3 acad-ex103_225.htm EX-10.3 694431
3 EX-31.1 acad-ex311_10.htm EX-31.1 9501
4 EX-31.2 acad-ex312_9.htm EX-31.2 9227
5 EX-32.1 acad-ex321_7.htm EX-32.1 6365
6 EX-32.2 acad-ex322_8.htm EX-32.2 6396
7 GRAPHIC gipi3jdjisqw000003.jpg GRAPHIC 56776
8 GRAPHIC gipi3jdjisqw000002.jpg GRAPHIC 74376
9 GRAPHIC gipi3jdjisqw000001.jpg GRAPHIC 14589
  Complete submission text file 0001564590-18-020524.txt   6290109

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT acad-20180630.xml EX-101.INS 1220733
11 XBRL TAXONOMY EXTENSION SCHEMA acad-20180630.xsd EX-101.SCH 34471
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20180630_cal.xml EX-101.CAL 50068
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20180630_def.xml EX-101.DEF 91965
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20180630_lab.xml EX-101.LAB 265991
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20180630_pre.xml EX-101.PRE 199824
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 181001852
SIC: 2834 Pharmaceutical Preparations